Advanced 3D tissue models possess a high potential to foster drug discovery and development, providing greater physiological relevance for in vitro testing. The inaugural New Frontiers Conference aims to establish an international forum in which to discuss integration of advanced 3D models throughout the drug discovery and development process, with an emphasis on translational approaches.
This one-day symposium will include sessions on current state-of-the-art 3D model systems for drug discovery and toxicology/safety testing, including keynote and invited speakers representing industry, regulatory, and academic perspectives on each topic. Poster abstracts submitted by July 25, 2016 will be considered for one of six attendee podium presentations.
Save the Date for the 1st New Frontiers in 3D Cell Culture – The 3D Cell Culture-based Screening Technologies Conference 2016, a collaboration of NIH/NCATS, Johns Hopkins/CAAT, (Promega) and InSphero.
Send us your request to receive more information for a full day of keynote sessions, talks and posters on 3D microtissue models for more relevant translational screening methods and safety testing.
Registration, abstract submission and preliminary program will be available soon.
Request more information here
October 13, 2016
John’s Hopkins University, Baltimore
Michael Gottesmann, PhD of Center of Cancer Research, NCI, NIH
New Systems to Analyze the Complexity of Drug Resistance in Cancer
Thomas Hartung, PhD of Johns Hopkins Bloomberg School of Public Health, Baltimore
The Age of Organoids – 21st century cell culture for 21st century science